Literature DB >> 7746171

Pre-pregnancy counselling for the primary prevention of birth defects: rubella vaccination and folate intake.

C R Marsack1, C L Alsop, J J Kurinczuk, C Bower.   

Abstract

OBJECTIVE: To describe women's experiences of pre-pregnancy counselling and their knowledge of rubella immunity and folate intake.
DESIGN: A cross-sectional sample of 121 public and 32 private patients at or less than 20 weeks' gestation attending their first antenatal appointment completed a self-administered questionnaire. MAIN OUTCOME MEASURES: Awareness of the importance of rubella immunity and folate intake; and the proportion of women who discussed these with their general practitioner (GP) before pregnancy.
RESULTS: Rubella: 59% correctly identified the effect of rubella infection in pregnancy and 86% had been vaccinated. Women born in Australia, New Zealand or the United Kingdom were nearly 16 times more likely to have been vaccinated against rubella than those born elsewhere. Folate: 54% knew of the protective effect of folate, 30% correctly identified the timing of this effect, 72% correctly identified some of the sources of dietary folate, and 13% had increased their folate intake before pregnancy. In 49% of women their GP was aware of their intention to conceive, but rubella had not been discussed with the GP before 50% of these planned pregnancies, and in 80% the issue of folate had not been discussed. Private patients were more likely to have had their rubella immune status checked and to have increased their folate intake compared with public patients.
CONCLUSIONS: Pre-pregnancy counselling about rubella immunity and folate intake is underused in the primary prevention of birth defects. Given the high proportion of unplanned pregnancies, primary prevention strategies for birth defects must involve all women of child-bearing age and not simply those planning a pregnancy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7746171

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  8 in total

1.  Low rate of adequate folic acid supplementation in well-educated women of high socioeconomic status attending a genetics clinic.

Authors:  L E Dawson; B Pham; A G Hunter
Journal:  CMAJ       Date:  2001-04-17       Impact factor: 8.262

2.  Consequences of surveying folate awareness.

Authors:  Lyndsey F Watson; Maxwell J Watson; Jane L Halliday; Robin J Bell
Journal:  Health Expect       Date:  2002-03       Impact factor: 3.377

3.  Health education needs for pregnancy: a study among women attending primary health centers.

Authors:  Parveen Rasheed; Latifa S Al-Sowielem
Journal:  J Family Community Med       Date:  2003-01

4.  Improving the uptake of preconception care and periconceptional folate supplementation: what do women think?

Authors:  Danielle Mazza; Anna Chapman
Journal:  BMC Public Health       Date:  2010-12-23       Impact factor: 3.295

Review 5.  Issues in the prevention of spina bifida.

Authors:  C Bower; F J Stanley
Journal:  J R Soc Med       Date:  1996-08       Impact factor: 18.000

6.  The Awareness of Pregnant Patient about Effect of Antibiotics in Pregnancy.

Authors:  Rehab Alsaleh; Shahad Gari; Maram Gari
Journal:  J Microsc Ultrastruct       Date:  2019 Apr-Jun

7.  Rubella Vaccination Coverage Among Women of Childbearing Age in Vietnam.

Authors:  Toan Thanh Thi Do; Anh Ngoc Nguyen; Xuan Thanh Thi Le; Ann Pongsakul; Quang Nhat Nguyen; Thanh Van Nguyen; Thang Huu Nguyen; Tri Minh Do; Huong Thi Le; Huong Lan Thi Nguyen; Nu Thi Truong; Chi Linh Hoang; Giang Thu Vu; Tung Thanh Tran; Tung Hoang Tran; Bach Xuan Tran; Carl A Latkin; Cyrus Sh Ho; Roger Cm Ho
Journal:  Int J Environ Res Public Health       Date:  2019-05-16       Impact factor: 3.390

8.  Barriers to the implementation of preconception care guidelines as perceived by general practitioners: a qualitative study.

Authors:  Danielle Mazza; Anna Chapman; Susan Michie
Journal:  BMC Health Serv Res       Date:  2013-01-31       Impact factor: 2.655

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.